Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Inotiv, Inc. Board/Management Information 2003

Nov 6, 2003

34595_rns_2003-11-06_b040194e-0eac-45f1-ac78-bc62c890a2ce.zip

Board/Management Information

Open in viewer

Opens in your device viewer

8-K 1 bas8k.htm BAS 8K DATED OCTOBER 31, 2003 Bioanalytical Systems, Inc. - Form 8K (dated 10/31/2003

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549

FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

Date of Report (Date of earliest event reported): October 31, 2003

BIOANALYTICAL SYSTEMS, INC. (Exact name of registrant as specified in its charter)

Indiana 0-23357 35-1345024
(State or other jurisdiction of incorporation or organization) (Commission File Number) (IRS Employer Identification No.)
2701 Kent Avenue West Lafayette, Indiana 47906-1382
(Address of principal executive offices) (Zip Code)
(765) 463-4527
(Registrant's telephone number, including area code)

MARKER FORMAT-SHEET="Head Left" FSL="Workstation"

Item 5.

MARKER FORMAT-SHEET="Para Indent Lv 0-TNR" FSL="Default"

On October 30, 2003, Bioanalytical Systems, Inc. (the “Company”) issued the press release filed herewith as Exhibit 99.1, and incorporated herein by reference, announcing the resignation of its Chief Financial Officer, Douglas P. Wieten.

Item 7. Financial Statements and Exhibits.

MARKER FORMAT-SHEET="Para Indent Lv 0-TNR" FSL="Default"

The following exhibits are filed as a part of this report:

MARKER FORMAT-SHEET="Head Sub 2 Left" FSL="Default"

(c) Exhibits

99.1 Press release, dated October 30, 2003, announcing the resignation of its Chief Financial Officer, Douglas P. Wieten.

MARKER FORMAT-SHEET="Head Major Center Bold" FSL="Workstation"

SIGNATURES

MARKER FORMAT-SHEET="Para Indent Lv 0-TNR" FSL="Default"

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

Date: November 6, 2003 BIOANALYTICAL SYSTEMS, INC. (Registrant) By: /s/ Michael P. Silvon Michael P. Silvon Vice President, Planning and Development Interim Chief Financial Officer and Treasurer

MARKER FORMAT-SHEET="Head Major Center Bold 1" FSL="Default"

Exhibit Index

Item Number assigned in Regulation S-K Exhibit Description of Exhibits

99 (99.1) Press release dated October 31, 2003